Evidence map›Paper›PMID 32393438›Full record

ArticleeLife2020

Intelligent classification of platelet aggregates by agonist type.

Yuqi Zhou, Atsushi Yasumoto, Cheng Lei, Chun-Jung Huang, Hirofumi Kobayashi, Yunzhao Wu, Sheng Yan, Chia-Wei Sun, Yutaka Yatomi, Keisuke Goda

Abstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Real-time intelligent classification of COVID-19 and thrombosis via massive image-based analysis of platelet aggregates.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023
    Article
  17. Review
  18. Article
  19. Long-term effects of Pfizer-BioNTech COVID-19 vaccinations on platelets.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuqi Zhou *Department of Chemistry, University of Tokyo, Tokyo, Japan.ORCID 0000-0002-1206-0049
Atsushi Yasumoto *Department of Clinical Laboratory Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Cheng LeiDepartment of Chemistry, University of Tokyo, Tokyo, Japan.ORCID 0000-0001-8439-4235
Chun-Jung HuangDepartment of Photonics, National Chiao Tung University, Hsinchu, Taiwan.
Hirofumi KobayashiDepartment of Chemistry, University of Tokyo, Tokyo, Japan.ORCID 0000-0002-4505-2061
Yunzhao WuDepartment of Chemistry, University of Tokyo, Tokyo, Japan.
Sheng YanDepartment of Chemistry, University of Tokyo, Tokyo, Japan.
Chia-Wei SunDepartment of Photonics, National Chiao Tung University, Hsinchu, Taiwan.
Yutaka YatomiDepartment of Clinical Laboratory Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Keisuke GodaDepartment of Chemistry, University of Tokyo, Tokyo, Japan.ORCID 0000-0001-6302-6038

Funding

Government of Japan ImPACT ProgramJapan Society for the Promotion of Science Core-to-Core ProgramUniversity of Tokyo Center for Nano Lithography
6 · The paper itself

Abstract

Platelets are anucleate cells in blood whose principal function is to stop bleeding by forming aggregates for hemostatic reactions. In addition to their participation in physiological hemostasis, platelet aggregates are also involved in pathological thrombosis and play an important role in inflammation, atherosclerosis, and cancer metastasis. The aggregation of platelets is elicited by various agonists, but these platelet aggregates have long been considered indistinguishable and impossible to classify. Here we present an intelligent method for classifying them by agonist type. It is based on a convolutional neural network trained by high-throughput imaging flow cytometry of blood cells to identify and differentiate subtle yet appreciable morphological features of platelet aggregates activated by different types of agonists. The method is a powerful tool for studying the underlying mechanism of platelet aggregation and is expected to open a window on an entirely new class of clinical diagnostics, pharmacometrics, and therapeutics.

Indexed as

Neural Networks, ComputerPlatelet AggregationFlow CytometryHumansLab-On-A-Chip DevicesMicrofluidic Analytical TechniquesPlatelet ActivationThrombosisbloodcell biologydeep learninghumanhuman biologyimaging flow cytometrymedicinemicrofluidicsplateletthrombosis

Identifiers

PMID32393438
PMCPMC7217700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.